Navigation Links
Luminex Corporation Announces Agreement to Acquire EraGen Biosciences, Inc.
Date:6/21/2011

trength," said Irene Hrusovsky, M.D., president and CEO of EraGen Biosciences. "As one of America's fastest growing companies, Luminex will benefit from EraGen's innovative technologies and expertise to penetrate new segments. I am confident that the company will realize significant business and technology synergies as Luminex brings the global reach and scale required to effectively leverage the enormous potential of EraGen's franchise in molecular diagnostics."

Current EraGen products include the MultiCode-RTx Herpes Simplex Virus (HSV) 1&2 Kit, the first FDA cleared PCR-based qualitative test for the detection and typing of HSV-1 or HSV-2 from vaginal lesion swab specimens.  The company also has several analyte specific reagents (ASRs) for detection of infectious agents and has developed research use only (RUO) reagents for infectious diseases associated with organ transplants.

Founded in 1999 and located in Madison, Wisconsin; EraGen has approximately 70 employees as well as a 27,000 sq. foot ISO 13485:2003 and CMDCAS certified facility. Luminex anticipates operations will remain in Madison, WI.

Financial Details

Under the terms of the agreement, Luminex will pay approximately $34 million in cash to acquire EraGen, which generated approximately $8.0 million in product revenue during 2010.  Luminex expects the EraGen acquisition will add between $5 million and $7 million to 2011 consolidated revenue.  

Luminex expects to record charges for non-recurring cash and non-cash acquisition-related costs in connection with the transaction. The full extent of these charges will not be determined under the rules of purchase accounting until valuation has been completed.  In addition, transaction-related professional fees will be expensed as incurred, as required by GAAP per ASC 805 "Business Combinations."

On a GAAP basis, inclusive of purchase related costs, Luminex expects this acquisition to be dilutive
'/>"/>

SOURCE Luminex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Luminex and Life Technologies Sign Agreement for Global Distribution of the Award-Winning MAGPIX® Multiplexing Instrument
2. Luminex Corporation to Present at Jefferies 2011 Global Healthcare Conference
3. Luminex Corporation Reports First Quarter 2011 Results
4. Luminex Corporation First Quarter Earnings Release Scheduled for May 9, 2011
5. Luminex Corporation Wins Prestigious Medical Design Excellence Award
6. Luminex Corporation to Present at Cowen and Companys 31st Annual Health Care Conference
7. Luminex Corporation Ranked One of the 25 Fastest-Growing Technology Companies in America by Forbes for Third Consecutive Year
8. Luminex and Partners HealthCare Announce Collaboration Agreement
9. Luminex Corporation Reports Fourth Quarter and Full Year 2010 Results
10. Luminex Corporation Fourth Quarter and Full Year 2010 Earnings Release Scheduled for February 7, 2011
11. Luminex Corporation to Present at JP Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014 Research and Markets has ... Therapeutics Market & Pipeline Insight 2014" report to ... to prevent and eradicate the prevalence of cancer have ... confined to low specificity, safety and large number of ... a better solution. It has been discovered that peptides ...
(Date:8/29/2014)... 29, 2014  United Therapeutics Corporation (NASDAQ: ... for the District of New Jersey ... case against Sandoz, Inc. regarding United Therapeutics, Remodulin ® ... ruled that U.S. Patent No. 6,765,117 is both valid ... marketing its generic product until the expiration of that ...
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire-iReach/ -- ChemImage will present a ... and New Zealand Forensic Science Society,s 22 nd ... Adelaide, Australia .  Forensic Scientists ... advancements that hyperspectral imaging can bring to examination ... , Director of Product Development at ChemImage, will ...
Breaking Medicine Technology:Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2District Court Decision Received In Remodulin Patent Case 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3
... Where do you start when trying to minimize the ... independent nonprofit that researches the best approaches to improving patient ... its 5th annual list of Top 10 Health Technology ... download with registration, the list features the top 10 ...
... Dec. 7, 2010 Millennium Research Group (MRG), the ... release their latest data on the US clot management ... for Clot Management Devices 2011 report provides important ... and the complex competitive dynamics of medical device manufacturers ...
Cached Medicine Technology:ECRI Institute Releases 'Top 10 Health Technology Hazards for 2011' 2ECRI Institute Releases 'Top 10 Health Technology Hazards for 2011' 3Millennium Research Group to Release Their Latest US Clot Management Data 2
(Date:8/29/2014)... As reported by CNN.com in the article ... process of admitting that you need help for a prescription ... and highlights the fact that if you simply try to ... overwhelmed by all of the information that is available online. ... through, it is still possible to get help. The statistics ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 According to new ... But Not Peer Pressure, Key to Prescription Drug Misuse Among ... primary focus for 18-29 year olds when it comes to ... the for this age group the real problem which influences ... drug associations and recreational use of them to have fun ...
(Date:8/29/2014)... article entitled How Genes, Gender and Environment Influence Substance ... gender and the environment that an individual is in affect ... Indiana University are taking another look at the fact that ... this factor to what is known about the influences of ... ties can help to reduce a man’s risk for abusing ...
(Date:8/29/2014)... 29, 2014 Formed in 2014, KAJ Brothers ... beyond their years. Their sophisticated Pop/R&B sound, with beautiful ... is fortunate enough to experience every day. , ... uplifted and feeling loved with the primary purpose of elevating ... this, the group unanimously replied - “To make chivalry cool ...
(Date:8/29/2014)... Mirada, CA (PRWEB) August 29, 2014 ... which will give patients the convenience of visiting ... with Healthpointe doctors through telemedicine. , Healthpointe doctors are ... calls (or audio). If necessary, the doctor can even ... assessed the patient’s condition, he or she can prescribe ...
Breaking Medicine News(10 mins):Health News:What to Know When Seeking Drug Addiction Help 2Health News:What to Know When Seeking Drug Addiction Help 3Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 2Health News:Peer Pressure Irrelevant in Prescription Drug Abuse for Young Adults 3Health News:Substance Abuse Likelihood Affected by Environment, Gender and Genes 2Health News:Substance Abuse Likelihood Affected by Environment, Gender and Genes 3Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 2Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 3Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 4Health News:Virtual Doctor’s Appointments Now Available at Healthpointe 2
... WASHINGTON, June 4 Walgreen Co. of,Deerfield, Ill., ... claims that from,2001 to 2005, it improperly switched ... Fluoxetine and Eldepryl in order to,increase its reimbursement ... which operates over 5,000 retail pharmacies throughout the,U.S., ...
... TORONTO, June 4 /PRNewswire-FirstCall/ - Predictive medicine company,PreMD Inc. ... appeal the,recent decision made by American Stock Exchange (the ... appeal determination process, the,Company,s stock will continue to trade ... to trade on the Toronto Stock Exchange (the "TSX"),under ...
... patients who lose nerve signals , , WEDNESDAY, June 4 ... improved after receiving human neural stem cell transplants, a ... substance that plays a critical role in the transmission ... missing or damaged, electrical signals aren,t properly transmitted. These ...
... (48%) of high,school teens say they have had sex--an increase ... by the Centers for Disease Control,and Prevention. During the same ... used a condom the last time they had sex decreased ... Youth Risk Behavior Surveillance,System. The survey is administered every two ...
... A failed drug launch can cost,a pharmaceutical ... end,up costing a company more. Leading pharmaceutical companies ... sales with a re-launch, according to a,study by ... As best-in-class pharma companies have demonstrated, combining ...
... Two members of Easter Seals national,corporate partner family -- ... across the Chicagoland area to bring value to consumers, ... consumers visiting any Chicagoland CENTURY,21(R) office or open house ... or transferred prescription is brought to CVS/pharmacy for use ...
Cached Medicine News:Health News:Walgreens to Pay $35 Million to U.S., 46 States & Puerto Rico to Settle Medicaid Prescription Drug Fraud Allegations 2Health News:PreMD Appeals American Stock Exchange Delisting Notification 2Health News:Human Stem Cell Transplant Helps Brain-Impaired Mice 2Health News:Teen Sexual Activity Increases, Contraceptive Use Decreases 2Health News:Redefining a Product's Identity Key to a Successful Re-Launch 2Health News:CVS/pharmacy and CENTURY 21(R) Team Up With Easter Seals Around Chicagoland 2
Coude Foley Catheters (Latex) 2-Way Amber...
Silicone Elastomer-Coated Latex Foley Catheters 3-Way...
Silicone Foley Catheters 3-Way...
Midstream Catch Kits...
Medicine Products: